Synthesis of novel benzothiazole amides: Evaluation of PPAR activity and anti-proliferative effects in paraganglioma, pancreatic and colorectal cancer cell lines

被引:18
作者
Ammazzalorso, Alessandra [1 ]
De Lellis, Laura [2 ,3 ]
Florio, Rosalba [2 ]
Laghezza, Antonio [4 ]
De Filippis, Barbara [1 ]
Fantacuzzi, Marialuigia [1 ]
Giampietro, Letizia [1 ]
Maccallini, Cristina [1 ]
Tortorella, Paolo [4 ]
Veschi, Serena [2 ]
Loiodice, Fulvio [4 ]
Cama, Alessandro [2 ,3 ]
Amoroso, Rosa [1 ]
机构
[1] Univ G dAnnunzio, Unita Chim Farmaceut, Dipartimento Farm, Chieti, Italy
[2] Univ G dAnnunzio, Unita Patol Gen, Dipartimento Farm, Chieti, Italy
[3] Univ G dAnnunzio, Aging Res Ctr CeSI, Chieti, Italy
[4] Univ Bari Aldo Moro, Dipartimento Farm Sci Farmaco, Via Orabona 4, I-70126 Bari, Italy
关键词
PPAR antagonists; Benzothiazoles; Amides; Anti-proliferative; Paraganglioma; Cytotoxicity; IN-VITRO; PEROXISOME; PROLIFERATION; FAMILY;
D O I
10.1016/j.bmcl.2019.06.020
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The reduced activation of PPARs has a positive impact on cancer cell growth and viability in multiple preclinical tumor models, suggesting a new therapeutic potential for PPAR antagonists. In the present study, the benzothiazole amides 2a-g were synthesized and their activities on PPARs were investigated. Transactivation assay showed a moderate activity of the novel compounds as PPAR alpha antagonists. Notably, in cellular assays they exhibited cytotoxicity in pancreatic, colorectal and paraganglioma cancer cells overexpressing PPAR alpha. In particular, compound 2b showed the most remarkable inhibition of viability (greater than 90%) in two paraganglioma cell lines, with IC50 values in the low micromolar range. In addition, 2b markedly impaired colony formation capacity in the same cells. Taken together, these results show a relevant anti-proliferative potential of compound 2b, which appears particularly effective in paraganglioma, a rare tumor poorly responsive to chemotherapy.
引用
收藏
页码:2302 / 2306
页数:5
相关论文
共 26 条
[1]  
Aboud OA, 2015, AM J PHYSIOL, V308, P890
[2]   The First Approved Agent in the Glitazar's Class: Saroglitazar [J].
Agrawal, Ritesh .
CURRENT DRUG TARGETS, 2014, 15 (02) :151-155
[3]   Cytotoxic effect of a family of peroxisome proliferator-activated receptor antagonists in colorectal and pancreatic cancer cell lines [J].
Ammazzalorso, Alessandra ;
De Lellis, Laura ;
Florio, Rosalba ;
Bruno, Isabella ;
De Filippis, Barbara ;
Fantacuzzi, Marialuigia ;
Giampietro, Letizia ;
Maccallini, Cristina ;
Perconti, Silvia ;
Verginelli, Fabio ;
Cama, Alessandro ;
Amoroso, Rosa .
CHEMICAL BIOLOGY & DRUG DESIGN, 2017, 90 (05) :1029-1035
[4]   Synthesis, in vitro evaluation, and molecular modeling investigation of benzenesulfonimide peroxisome proliferator-activated receptors α antagonists [J].
Ammazzalorso, Alessandra ;
Carrieri, Antonio ;
Verginelli, Fabio ;
Bruno, Isabella ;
Carbonara, Giuseppe ;
D'Angelo, Alessandra ;
De Filippis, Barbara ;
Fantacuzzi, Marialuigia ;
Florio, Rosalba ;
Fracchiolla, Giuseppe ;
Giampietro, Letizia ;
Giancristofaro, Antonella ;
Maccallini, Cristina ;
Cama, Alessandro ;
Amoroso, Rosa .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 114 :191-200
[5]   Blocking the Peroxisome Proliferator-Activated Receptor (PPAR): An Overview [J].
Ammazzalorso, Alessandra ;
De Filippis, Barbara ;
Giampietro, Letizia ;
Amoroso, Rosa .
CHEMMEDCHEM, 2013, 8 (10) :1609-1616
[6]   Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARα [J].
Ammazzalorso, Alessandra ;
D'Angelo, Alessandra ;
Giancristofaro, Antonella ;
De Filippis, Barbara ;
Di Matteo, Mauro ;
Fantacuzzi, Marialuigia ;
Giampietro, Letizia ;
Linciano, Pasquale ;
Maccallini, Cristina ;
Amoroso, Rosa .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 58 :317-322
[7]   Benzothiazole-based N-(phenylsulfonyl)amides as a novel family of PPARα antagonists [J].
Ammazzalorso, Alessandra ;
Giancristofaro, Antonella ;
D'Angelo, Alessandra ;
De Filippis, Barbara ;
Fantacuzzi, Marialuigia ;
Giampietro, Letizia ;
Maccallini, Cristina ;
Amoroso, Rosa .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (16) :4869-4872
[8]   Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells [J].
Bao, Bin ;
Wang, Zhiwei ;
Ali, Shadan ;
Ahmad, Aamir ;
Azmi, Asfar S. ;
Sarkar, Sanila H. ;
Banerjee, Sanjeev ;
Kong, Dejuan ;
Li, Yiwei ;
Thakur, Shivam ;
Sarkar, Fazlul H. .
CANCER PREVENTION RESEARCH, 2012, 5 (03) :355-364
[9]   PPARα Antagonist AA452 Triggers Metabolic Reprogramming and Increases Sensitivity to Radiation Therapy in Human Glioblastoma Primary Cells [J].
Benedetti, Elisabetta ;
D'Angelo, Michele ;
Ammazzalorso, Alessandra ;
Gravina, Giovanni Luca ;
Laezza, Chiara ;
Antonosante, Andrea ;
Panella, Gloria ;
Cinque, Benedetta ;
Cristiano, Loredana ;
Dhez, Anne Chloe ;
Astarita, Carlo ;
Galzio, Renato ;
Cifone, Maria Grazia ;
Ippoliti, Rodolfo ;
Amoroso, Rosa ;
Di Cesare, Ernesto ;
Giordano, Antonio ;
Cimini, Annamaria .
JOURNAL OF CELLULAR PHYSIOLOGY, 2017, 232 (06) :1458-1466
[10]   PPARs: therapeutic targets for metabolic disease [J].
Berger, JP ;
Akiyama, TE ;
Meinke, PT .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (05) :244-251